HIV-1
Conditions
Brief summary
Proportion of PLHIV ≥ 60 years on stable ART that switch to CAB LA + RPV LA with plasma HIV-1 RNA ≥50 copies per mL at month 12 in the intention-to-treat exposed (ITT-E) population, per the US Food and Drug Administration’s Snapshot algorithm.
Interventions
Sponsors
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of PLHIV ≥ 60 years on stable ART that switch to CAB LA + RPV LA with plasma HIV-1 RNA ≥50 copies per mL at month 12 in the intention-to-treat exposed (ITT-E) population, per the US Food and Drug Administration’s Snapshot algorithm. | — |
Countries
Spain
Outcome results
None listed